Stefania E Makariou
Overview
Explore the profile of Stefania E Makariou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makariou S, Challa A, Siomou E, Tellis C, Tselepis A, Elisaf M, et al.
Arch Med Sci Atheroscler Dis
. 2020 Jun;
5:e64-e71.
PMID: 32529108
Introduction: Obesity is associated with cardiovascular disease (CVD) risk factors as well as decreased 25(OH) vitamin D serum levels. We aimed to study 25(OH) vitamin D levels in adolescents with...
2.
Makariou S, Elisaf M, Challa A, Tellis C, Tselepis A, Liberopoulos E
Clin Nutr ESPEN
. 2019 Jan;
29:198-202.
PMID: 30661687
Background: Metabolic syndrome (MetS) patients can have low 25-hydroxyvitamin D 25(OH)VitD levels, which may be associated with increased oxidative stress. There is little data on the effect of 25(OH)VitD administration...
3.
Makariou S, Elisaf M, Challa A, Tentolouris N, Liberopoulos E
Arch Med Sci Atheroscler Dis
. 2017 Dec;
2:e52-e60.
PMID: 29242845
Introduction: Patients with metabolic syndrome (MetS) may have lower 25-hydroxyvitamin D (25(OH)VitD) serum levels compared with non-MetS individuals. Vitamin D (VitD) deficiency is associated with various cardiovascular disease (CVD) risk...
4.
Challa A, Makariou S, Siomou E
J Pediatr Endocrinol Metab
. 2015 Jun;
28(11-12):1235-45.
PMID: 26053006
Among children and adolescents, metabolic syndrome (MetS) is more common than previously believed. Hence, any information on the relation between vitamin D insufficiency/deficiency and insulin resistance (IR) in this population...
5.
Liberopoulos E, Makariou S, Moutzouri E, Kostapanos M, Challa A, Elisaf M
J Cardiovasc Pharmacol Ther
. 2013 Jan;
18(3):229-33.
PMID: 23288870
Background: Low levels of 25-hydroxyvitamin D (25(OH)VitD) have been recognized as an emerging cardiovascular disease (CVD) risk factor. Statins are reported to increase 25(OH)VitD concentration. Animal studies suggest that ezetimibe...
6.
Makariou S, Michel P, Tzoufi M, Challa A, Milionis H
Curr Vasc Pharmacol
. 2012 Jun;
12(1):117-24.
PMID: 22724468
The role of vitamin D (VitD) has recently been expanded beyond bone homeostasis and regulation of calcium levels. VitD deficiency has been proposed as a new risk factor for cardiovascular...
7.
Makariou S, Liberopoulos E, Agouridis A, Challa A, Elisaf M
J Cardiovasc Pharmacol Ther
. 2012 Mar;
17(4):382-6.
PMID: 22431864
Background: Low levels of 25(OH) vitamin D [25(OH)VitD] have been recognized as a new cardiovascular disease (CVD) risk factor. Statins seem to increase 25(OH)VitD concentration. Aim: To investigate whether combined...